NDC codes

FDA NDC Directory
Product NDC (as listed)63187-978Labeler and product segments. Claims need a package NDC.
Product NDC at billing width63187-0978Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
63187-978-306318709783030 TABLET in 1 BOTTLE (63187-978-30)Marketed from Feb 1, 2018
63187-978-606318709786060 TABLET in 1 BOTTLE (63187-978-60)Marketed from Feb 1, 2018
63187-978-906318709789090 TABLET in 1 BOTTLE (63187-978-90)Marketed from Feb 1, 2018

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Isoniazid
Generic name (nonproprietary)
isoniazid
Active ingredients
Isoniazid300 mg/1
Dosage form
Tablet
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 080937
Marketing start
Listing expires
Identifiers
Product ID 63187-978_5c1e5064-9311-4161-a11f-1e006dd97bfbSPL ID 5c1e5064-9311-4161-a11f-1e006dd97bfbSPL set ID 65e50989-d24c-4bb3-a041-d6aea2635ef1RxCUI 197832UNII V83O1VOZ8L
Pharmacologic class
Antimycobacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N463187097830 followed by a unit qualifier and the quantity

Package 63187-0978-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective . This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS AND USAGE Isoniazid tablets are recommended for all forms of tuberculosis in which organisms are susceptible. However, active tuberculosis must be treated with multiple concomitant anti-tuberculosis medications to prevent the emergence of drug resistance. Single-drug treatment of active tuberculosis with isoniazid or any other medication, is inadequate therapy. Isoniazid tablets are recommended as preventive therapy for the following groups, regardless of age. (Note: the criterion for a positive reaction to a skin test (in millimeters of induration) for each group is given in parenthesis): 1. Persons with human immunodeficiency virus (HIV) infection (greater than or equal to 5 mm

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 080937

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 080937
ProductStrengthForm · routeLabelerProduct NDC
IsoniazidIsoniazid 300 mg/1TabletOralTeva Pharmaceuticals USA, Inc.0555-0071
IsoniazidIsoniazid 300 mg/1TabletOralREMEDYREPACK INC.70518-4315
IsoniazidIsoniazid 300 mg/1TabletOralGenus Lifesciences64950-217
IsoniazidIsoniazid 300 mg/1TabletOralCoupler LLC67046-1570
IsoniazidIsoniazid 300 mg/1TabletOralBryant Ranch Prepack71335-2760
IsoniazidIsoniazid 300 mg/1TabletOralMylan Institutional Inc.51079-083
IsoniazidIsoniazid 300 mg/1TabletOralBryant Ranch Prepack71335-2800
IsoniazidIsoniazid 300 mg/1TabletOralAphena Pharma Solutions - Tennessee, LLC71610-395
IsoniazidIsoniazid 300 mg/1TabletOralA-S Medication Solutions50090-0370

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in